These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 38853244

  • 1. Early detection of pancreatic cancer by liquid biopsy "PANLIPSY": a french nation-wide study project.
    Bardol T, Dujon AM, Taly V, Dunyach-Remy C, Lavigne JP, Costa-Silva B, Kurma K, Eslami-S Z, Cayrefourcq L, Canivet C, Muscari F, Bournet B, Alix-Panabières C.
    BMC Cancer; 2024 Jun 10; 24(1):709. PubMed ID: 38853244
    [Abstract] [Full Text] [Related]

  • 2. A prospective clinical and biological database for pancreatic adenocarcinoma: the BACAP cohort.
    Canivet C, Gourgou-Bourgade S, Napoléon B, Palazzo L, Flori N, Guibert P, Piessen G, Farges-Bancel D, Seitz JF, Assenat E, Vendrely V, Truant S, Vanbiervliet G, Berthelémy P, Garcia S, Gomez-Brouchet A, Buscail L, Bournet B, BACAP Consortium.
    BMC Cancer; 2018 Oct 16; 18(1):986. PubMed ID: 30326968
    [Abstract] [Full Text] [Related]

  • 3. High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients.
    Allenson K, Castillo J, San Lucas FA, Scelo G, Kim DU, Bernard V, Davis G, Kumar T, Katz M, Overman MJ, Foretova L, Fabianova E, Holcatova I, Janout V, Meric-Bernstam F, Gascoyne P, Wistuba I, Varadhachary G, Brennan P, Hanash S, Li D, Maitra A, Alvarez H.
    Ann Oncol; 2017 Apr 01; 28(4):741-747. PubMed ID: 28104621
    [Abstract] [Full Text] [Related]

  • 4. Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer.
    Mellby LD, Nyberg AP, Johansen JS, Wingren C, Nordestgaard BG, Bojesen SE, Mitchell BL, Sheppard BC, Sears RC, Borrebaeck CAK.
    J Clin Oncol; 2018 Oct 01; 36(28):2887-2894. PubMed ID: 30106639
    [Abstract] [Full Text] [Related]

  • 5. Multibiomarker panels in liquid biopsy for early detection of pancreatic cancer - a comprehensive review.
    Reese KL, Pantel K, Smit DJ.
    J Exp Clin Cancer Res; 2024 Sep 02; 43(1):250. PubMed ID: 39218911
    [Abstract] [Full Text] [Related]

  • 6. A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study.
    Debernardi S, O'Brien H, Algahmdi AS, Malats N, Stewart GD, Plješa-Ercegovac M, Costello E, Greenhalf W, Saad A, Roberts R, Ney A, Pereira SP, Kocher HM, Duffy S, Blyuss O, Crnogorac-Jurcevic T.
    PLoS Med; 2020 Dec 02; 17(12):e1003489. PubMed ID: 33301466
    [Abstract] [Full Text] [Related]

  • 7. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
    Castillo J, Bernard V, San Lucas FA, Allenson K, Capello M, Kim DU, Gascoyne P, Mulu FC, Stephens BM, Huang J, Wang H, Momin AA, Jacamo RO, Katz M, Wolff R, Javle M, Varadhachary G, Wistuba II, Hanash S, Maitra A, Alvarez H.
    Ann Oncol; 2018 Jan 01; 29(1):223-229. PubMed ID: 29045505
    [Abstract] [Full Text] [Related]

  • 8. Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma.
    Yu J, Ploner A, Kordes M, Löhr M, Nilsson M, de Maturana MEL, Estudillo L, Renz H, Carrato A, Molero X, Real FX, Malats N, Ye W.
    Int J Cancer; 2021 Apr 15; 148(8):2048-2058. PubMed ID: 33411965
    [Abstract] [Full Text] [Related]

  • 9. Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer.
    Dittmar RL, Liu S, Tai MC, Rajapakshe K, Huang Y, Longton G, DeCapite C, Hurd MW, Paris PL, Kirkwood KS, Coarfa C, Maitra A, Brand RE, Killary AM, Sen S.
    Cancer Prev Res (Phila); 2021 Jul 15; 14(7):729-740. PubMed ID: 33893071
    [Abstract] [Full Text] [Related]

  • 10. Mutant KRAS Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring.
    Perets R, Greenberg O, Shentzer T, Semenisty V, Epelbaum R, Bick T, Sarji S, Ben-Izhak O, Sabo E, Hershkovitz D.
    Oncologist; 2018 May 15; 23(5):566-572. PubMed ID: 29371474
    [Abstract] [Full Text] [Related]

  • 11. Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early pancreatic cancer detection.
    Ney A, Nené NR, Sedlak E, Acedo P, Blyuss O, Whitwell HJ, Costello E, Gentry-Maharaj A, Williams NR, Menon U, Fusai GK, Zaikin A, Pereira SP.
    PLoS Comput Biol; 2024 Aug 15; 20(8):e1012408. PubMed ID: 39208354
    [Abstract] [Full Text] [Related]

  • 12. Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification.
    Lindgaard SC, Sztupinszki Z, Maag E, Chen IM, Johansen AZ, Jensen BV, Bojesen SE, Nielsen DL, Hansen CP, Hasselby JP, Nielsen KR, Szallasi Z, Johansen JS.
    Clin Cancer Res; 2021 May 01; 27(9):2592-2603. PubMed ID: 33737308
    [Abstract] [Full Text] [Related]

  • 13. Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma.
    Khan IA, Rashid S, Singh N, Rashid S, Singh V, Gunjan D, Das P, Dash NR, Pandey RM, Chauhan SS, Gupta S, Saraya A.
    Sci Rep; 2021 Feb 02; 11(1):2824. PubMed ID: 33531550
    [Abstract] [Full Text] [Related]

  • 14. A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer.
    Balasenthil S, Huang Y, Liu S, Marsh T, Chen J, Stass SA, KuKuruga D, Brand R, Chen N, Frazier ML, Jack Lee J, Srivastava S, Sen S, McNeill Killary A.
    J Natl Cancer Inst; 2017 Aug 01; 109(8):. PubMed ID: 28376184
    [Abstract] [Full Text] [Related]

  • 15. An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study.
    Nakamura K, Zhu Z, Roy S, Jun E, Han H, Munoz RM, Nishiwada S, Sharma G, Cridebring D, Zenhausern F, Kim S, Roe DJ, Darabi S, Han IW, Evans DB, Yamada S, Demeure MJ, Becerra C, Celinski SA, Borazanci E, Tsai S, Kodera Y, Park JO, Bolton JS, Wang X, Kim SC, Von Hoff D, Goel A.
    Gastroenterology; 2022 Nov 01; 163(5):1252-1266.e2. PubMed ID: 35850192
    [Abstract] [Full Text] [Related]

  • 16. Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA.
    Wu H, Guo S, Liu X, Li Y, Su Z, He Q, Liu X, Zhang Z, Yu L, Shi X, Gao S, Wang H, Pan Y, Ma C, Liu R, Dai M, Jin G, Liang Z.
    BMC Med; 2022 Nov 25; 20(1):458. PubMed ID: 36434648
    [Abstract] [Full Text] [Related]

  • 17. Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer.
    Patel H, Okamura R, Fanta P, Patel C, Lanman RB, Raymond VM, Kato S, Kurzrock R.
    J Hematol Oncol; 2019 Dec 04; 12(1):130. PubMed ID: 31801585
    [Abstract] [Full Text] [Related]

  • 18. A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma.
    Xu C, Jun E, Okugawa Y, Toiyama Y, Borazanci E, Bolton J, Taketomi A, Kim SC, Shang D, Von Hoff D, Zhang G, Goel A.
    Gastroenterology; 2024 Jan 04; 166(1):178-190.e16. PubMed ID: 37839499
    [Abstract] [Full Text] [Related]

  • 19. Liquid Biopsy for Pancreatic Cancer by Serum Extracellular Vesicle-Encapsulated Long Noncoding RNA HEVEPA.
    Takahashi K, Inuzuka T, Shimizu Y, Sawamoto K, Taniue K, Ono Y, Asai F, Koyama K, Sato H, Kawabata H, Iwamoto H, Yamakita K, Kitano Y, Teramoto T, Fujiya M, Fujii S, Mizukami Y, Okumura T.
    Pancreas; 2024 May 01; 53(5):e395-e404. PubMed ID: 38416857
    [Abstract] [Full Text] [Related]

  • 20. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.
    Vila-Navarro E, Duran-Sanchon S, Vila-Casadesús M, Moreira L, Ginès À, Cuatrecasas M, Lozano JJ, Bujanda L, Castells A, Gironella M.
    Clin Transl Gastroenterol; 2019 Apr 01; 10(4):e00029. PubMed ID: 31009404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.